** Shares of Inari Medical rise 27.5% to a near one-year high of $63.47
** Medical device maker Stryker is in advanced talks to acquire NARI, which makes devices to treat patients with venous diseases, Reuters reports, citing people familiar with the matter
** If the talks are successful, a deal could be announced as soon as this week, the report said
** Deal would bolster SYK's efforts to build out its offerings to treat a condition called venous thromboembolism, where a blood clot forms in a vein, and other venous diseases
** NARI stock fell 21.4% in 2024
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。